122 related articles for article (PubMed ID: 18324409)
21. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY
Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341
[TBL] [Abstract][Full Text] [Related]
22. Immunohistological analysis of peptide-induced delayed-type hypersensitivity in advanced melanoma patients treated with melanoma antigen-pulsed mature monocyte-derived dendritic cell vaccination.
Nakai N; Katoh N; Germeraad WT; Kishida T; Ueda E; Takenaka H; Mazda O; Kishimoto S
J Dermatol Sci; 2009 Jan; 53(1):40-7. PubMed ID: 18804963
[TBL] [Abstract][Full Text] [Related]
23. A pilot study of human interferon beta gene therapy for patients with advanced melanoma by in vivo transduction using cationic liposomes.
Matsumoto K; Kubo H; Murata H; Uhara H; Takata M; Shibata S; Yasue S; Sakakibara A; Tomita Y; Kageshita T; Kawakami Y; Mizuno M; Yoshida J; Saida T
Jpn J Clin Oncol; 2008 Dec; 38(12):849-56. PubMed ID: 18945721
[TBL] [Abstract][Full Text] [Related]
24. [Interferon therapy in malignant melanoma].
Stadler R; Garbe C
Z Hautkr; 1990 May; 65(5):504-7. PubMed ID: 1696048
[TBL] [Abstract][Full Text] [Related]
25. Antitumor effect of human fibroblast interferon on the growth of human melanoma cells implanted in nude mice.
Ida N; Uenishi N; Kajita A; Satoh Y
Gan; 1982 Dec; 73(6):952-60. PubMed ID: 7160584
[TBL] [Abstract][Full Text] [Related]
26. [Clinical effect and histopathologic observation of malignant melanoma by intratumoral administration of HuIFN- beta].
Ishihara K; Hayasaka K; Yamamoto A
Gan No Rinsho; 1983 May; 29(6):603-7. PubMed ID: 6876428
[TBL] [Abstract][Full Text] [Related]
27. Model cell culture system for defining the molecular and biochemical events mediating terminal differentiation of human melanoma cells.
Staudt MR; Depass AL; Sarkar D; Fisher PB
J Cell Physiol; 2009 Feb; 218(2):304-14. PubMed ID: 18844238
[TBL] [Abstract][Full Text] [Related]
28. Chemoablation of metastatic melanoma using intralesional Rose Bengal.
Thompson JF; Hersey P; Wachter E
Melanoma Res; 2008 Dec; 18(6):405-11. PubMed ID: 18830132
[TBL] [Abstract][Full Text] [Related]
29. [Comment on the contribution by G. Fierlbeck, B. d'Hoedt, W. Stroebel, H. Stutte, O. Bogenschütz and G. Rassner. Intralesional therapy of melanoma metastases with recombinant interferon-beta].
Kölmel KF; Abel U
Hautarzt; 1993 May; 44(5):329-30. PubMed ID: 8320124
[No Abstract] [Full Text] [Related]
30. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
Hoch U; Lynch J; Sato Y; Kashimoto S; Kajikawa F; Furutani Y; Silverman JA
Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998
[TBL] [Abstract][Full Text] [Related]
31. Honeybee venom induces calcium-dependent but caspase-independent apoptotic cell death in human melanoma A2058 cells.
Tu WC; Wu CC; Hsieh HL; Chen CY; Hsu SL
Toxicon; 2008 Aug; 52(2):318-29. PubMed ID: 18602939
[TBL] [Abstract][Full Text] [Related]
32. Antitumor activity of Ru(III) complexes carrying beta-diketonato ligands in vitro and in vivo.
Arandjelovic SS; Bjelogrlic KS; Malesevic NN; Tesic LjZ; Radulovic SS
J BUON; 2009; 14(2):271-9. PubMed ID: 19650178
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of pancreatic cancer cell proliferation by propranolol occurs through apoptosis induction: the study of beta-adrenoceptor antagonist's anticancer effect in pancreatic cancer cell.
Zhang D; Ma Q; Shen S; Hu H
Pancreas; 2009 Jan; 38(1):94-100. PubMed ID: 19106745
[TBL] [Abstract][Full Text] [Related]
34. Local administration of PF-3512676 CpG-B instigates tumor-specific CD8+ T-cell reactivity in melanoma patients.
Molenkamp BG; Sluijter BJ; van Leeuwen PA; Santegoets SJ; Meijer S; Wijnands PG; Haanen JB; van den Eertwegh AJ; Scheper RJ; de Gruijl TD
Clin Cancer Res; 2008 Jul; 14(14):4532-42. PubMed ID: 18628468
[TBL] [Abstract][Full Text] [Related]
35. Tranilast inhibits hormone refractory prostate cancer cell proliferation and suppresses transforming growth factor beta1-associated osteoblastic changes.
Izumi K; Mizokami A; Li YQ; Narimoto K; Sugimoto K; Kadono Y; Kitagawa Y; Konaka H; Koh E; Keller ET; Namiki M
Prostate; 2009 Aug; 69(11):1222-34. PubMed ID: 19434660
[TBL] [Abstract][Full Text] [Related]
36. Polysaccharides isolated from Phellinus gilvus inhibit melanoma growth in mice.
Bae JS; Jang KH; Yim H; Jin HK
Cancer Lett; 2005 Jan; 218(1):43-52. PubMed ID: 15639339
[TBL] [Abstract][Full Text] [Related]
37. Anticancer properties of chitosan on human melanoma are cell line dependent.
Gibot L; Chabaud S; Bouhout S; Bolduc S; Auger FA; Moulin VJ
Int J Biol Macromol; 2015 Jan; 72():370-9. PubMed ID: 25193096
[TBL] [Abstract][Full Text] [Related]
38. Differential sensitivity of breast cancer and melanoma cells to proteasome inhibitor Velcade.
Yerlikaya A; Erin N
Int J Mol Med; 2008 Dec; 22(6):817-23. PubMed ID: 19020781
[TBL] [Abstract][Full Text] [Related]
39. Human fibroblast interferon in human neoplasia: clinical and laboratory study.
Horoszewicz JS; Leong SS; Ito M; Buffett RF; Karakousis C; Holyoke E; Job L; Dölen JG; Carter WA
Cancer Treat Rep; 1978 Nov; 62(11):1899-906. PubMed ID: 728909
[TBL] [Abstract][Full Text] [Related]
40. Variable cytotoxicity of amifostine in malignant and non-malignant cell lines.
Brenner B; Wasserman L; Beery E; Nordenberg J; Schechter J; Gutman H; Fenig E
Oncol Rep; 2003; 10(5):1609-13. PubMed ID: 12883748
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
